Is Biohaven Ltd (NYSE: BHVN) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

BHVN belongs to the Healthcare sector of the NYSE while operating in the Biotechnology industry. The current market capitalization of Biohaven Ltd is $3.08B. A total of 0.57 million shares were traded on the day, compared to an average of 1.16M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, BHVN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 8 BUYs and 0 SELLs from insiders. Insiders purchased 1,099,634 shares during that period but sold 0.

In the most recent transaction, Antonijevic Irina sold 11,000 shares of BHVN for 41.79 per share on Dec 29. After the transaction, the Director now owns 2,535 company shares. In a previous transaction on Oct 05, CHILDS JOHN W bought 454,545 shares at 22.00 per share. BHVN shares that Director owns now total 3,998,952.

Among the insiders who bought shares, Coric Vlad acquired of 340,908 shares on Oct 05 at a per-share price of $22.00. This resulted in the Chief Executive Officer holding 833,120 shares of BHVN after the transaction. In another insider transaction, Coric Vlad bought 113,637 shares at $22.00 per share on Oct 05. Company shares held by the Chief Executive Officer now total 1,657,031.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BHVN has a high of $49.65 and a low of $12.35.

As of this writing, BHVN has an earnings estimate of -$1.42 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$1.14 per share and a lower estimate of -$1.62. The company reported an EPS of -$1.32 in the last quarter, which was -9.10% lower than expectations of -$1.21.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BHVN’s latest balance sheet shows that the firm has $76.06M in Cash & Short Term Investments as of fiscal 2021. There were $2.80M in debt and $41.94M in liabilities at the time. Its Book Value Per Share was $4.24, while its Total Shareholder’s Equity was $94.69M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BHVN is Buy with a score of 5.00.

Most Popular

Related Posts